<DOC>
	<DOC>NCT01405794</DOC>
	<brief_summary>The investigators propose to study oral commercial silver nanoparticle products on human enzyme activity.</brief_summary>
	<brief_title>In-Vivo Assessment of Silver Biomaterial Nano-Toxicity 32 Ppm</brief_title>
	<detailed_description />
	<criteria>1880 years old without debilitating chronic disease or history of cardiovascular event. Women physically capable of becoming pregnant, who are not using 2 barrier methods of birth control; Any female who is nursing; History of heavy metal allergy; History of asthma or Chronic Obstructive Pulmonary Disease; History of renal impairment; Symptoms of active upper respiratory disease at time of consent; Smoking more than 5 cigarettes or equivalent and not able to stop for 48 hours; Ability to discontinue chronic medications or nutraceuticals for 20 days or 5 halflives of the agent, whichever is longer.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>September 2015</verification_date>
</DOC>